1. Home
  2. ACCO vs VNDA Comparison

ACCO vs VNDA Comparison

Compare ACCO & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$4.22

Market Cap

353.3M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$5.06

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCO
VNDA
Founded
1893
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.3M
361.4M
IPO Year
2005
2005

Fundamental Metrics

Financial Performance
Metric
ACCO
VNDA
Price
$4.22
$5.06
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$5.00
$14.90
AVG Volume (30 Days)
608.8K
810.4K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
9.26%
N/A
EPS Growth
141.51
N/A
EPS
0.20
N/A
Revenue
$1,524,700,000.00
$216,105,000.00
Revenue This Year
$3.10
$21.35
Revenue Next Year
$0.89
$37.40
P/E Ratio
$21.15
N/A
Revenue Growth
N/A
8.72
52 Week Low
$2.81
$4.14
52 Week High
$4.39
$9.91

Technical Indicators

Market Signals
Indicator
ACCO
VNDA
Relative Strength Index (RSI) 57.81 32.17
Support Level $3.73 N/A
Resistance Level $4.36 $5.46
Average True Range (ATR) 0.14 0.21
MACD 0.02 -0.04
Stochastic Oscillator 73.00 9.72

Price Performance

Historical Comparison
ACCO
VNDA

About ACCO Acco Brands Corporation

ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: